查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1470452

血液篩檢市場：按產品和服務、技術、最終用戶分類 - 全球預測 2024-2030

Blood Screening Market by Product & Service (Instruments, Outright Purchase, Reagents & Kits), Technology (ELISA, NAT, NGS), End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年血液篩檢市場規模為49億美元，預計2024年將達53.1億美元，2030年將達88.2億美元，複合年成長率為8.74%。

血液篩檢是醫療保健的一個重要方面，涉及對血液樣本的分析和測試，以發現潛在的健康問題、感染疾病和疾病。它作為重要的診斷和監測工具，確保輸血和器官移植的安全，並追蹤人群中各種疾病的流行。由於全球捐血/輸血的增加、感染疾病的流行以及分子診斷技術的進步，對血液篩檢的需求正在增加。然而，引進新技術帶來的高昂前期成本以及低度開發地區對可用工具缺乏認知，嚴重阻礙了血液篩檢的採用。此外，專注於次世代定序(NGS)、CRISPR 基因編輯技術和人工智慧 (AI) 診斷應用的製造商為提高測試準確性、速度和成本效率提供了有希望的途徑。製造商正在識別多種疾病的新型生物標記物，並增強早期檢測能力，改善患者的治療結果，並增加對先進血液篩檢測試的需求。

主要市場統計
基準年[2023] 49億美元
預測年份 [2024] 53.1億美元
預測年份 [2030] 88.2億美元
複合年成長率（%） 8.74%

產品：更多採用設備和耗材來執行準確的測試

血液篩檢過程在很大程度上依賴能夠對多種病原體進行快速、準確檢測的先進設備。這些儀器有助於檢測傳染源，並允許醫療專業人員量化給定樣本中傳染源的存在。耗材有助於準確、高效的測試，同時最大限度地降低樣品之間交叉污染的風險。血液篩檢用品包括微量移液器微量吸管尖、微孔盤、過濾器吸頭和試管、比色皿和管瓶、注射器過濾器和其他一次性設備。血液篩檢也嚴重依賴與樣本中特定病原體或化合物發生反應並產生可測量訊號以表明感染源存在的各種試劑。

技術：酵素結合免疫吸附檢測法和質譜技術的開發

核酸檢測 (NAT) 是一種靈敏的分子技術，可檢測血液樣本中的微量病毒核酸。酵素結合免疫吸附檢測法(ELISA) 是一種免疫檢測，篩檢檢體血液樣本中與愛滋病毒、乙型和丙型肝炎以及梅毒等感染疾病相關的抗體和抗原。聚合酵素鏈鎖反應(PCR) 是另一種廣泛使用的分子診斷方法，可快速檢測給定樣本中的特定核酸序列。質譜 (MS) 是一種根據質荷比 (m/z) 來識別和表徵分子的分析過程。流式細胞技術是一種基於細胞的技術，可透過測量細胞透過雷射光束時的光散射來快速分析細胞特性。

應用：防止感染疾病傳播，廣泛應用於感染疾病和癌症的篩檢。

感染疾病的血液篩檢對於支持公共衛生和預防感染疾病的傳播至關重要。血型測試是一項重要的血液篩檢過程，用於確定個人的血型（ABO 公式）和 Rh 因子（陽性或陰性）。隨著診斷技術的進步，透過癌症特異性血液篩檢進行早期檢測變得越來越重要。基因血液檢查透過分析 DNA 來識別遺傳性疾病、評估某種特定疾病的風險並指導個人化治療計劃。

最終用戶：醫院和實驗室更多地使用血液篩檢

醫院和診所是需要進行血液檢查作為治療或診斷一部分的患者的主要聯繫點。醫院和診所現場收集和處理樣本或將其發送到外部測試實驗室進行進一步分析。診斷實驗室專門使用各種測試方法分析生物樣本，包括核酸擴增檢驗 (NAAT)、酵素結合免疫吸附檢測法(ELISA) 和化學冷光免疫檢測(CIA)。對於輸血，血庫收集、儲存、處理、測試和分配血液製品，例如全血、血漿、血小板、紅血球和白血球。包括大學、政府機構和私人組織在內的研究機構正在為血液篩檢新技術和方法的開發做出貢獻。

區域洞察

由於先進的醫療保健系統、高品質的研究機構和技術創新資金，美洲對血液篩檢測試的需求不斷增加。美國食品藥物管理局(FDA) 已核准大量新型血液篩檢技術，以確保其安全性和有效性。由於經濟快速成長、醫療基礎設施不斷擴大以及人口密度高，亞太地區擁有大量易患感染疾病的患者群體。在過去的輸血相關醜聞之後，中國最近實施了嚴格的血液安全法規，導致對先進篩檢技術的需求增加。歐盟（EU）國家擁有高度發展的醫療體系和嚴格的輸血服務法規。對新型診斷技術研發活動的投資正在促進歐洲血液篩檢產業的蓬勃發展。中東和非洲地區是一個多元化的地區，醫療基礎設施發展水準參差不齊。許多非洲國家面臨基礎設施和資源不足的挑戰，無法確保安全輸血，為受血者帶來健康風險。

FPNV定位矩陣

FPNV定位矩陣對於評估血液篩檢市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限。最前線 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對血液篩檢市場中供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該細分市場競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：包括新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：包括對未來技術、研發活動以及突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.血液篩檢市場規模及預測如何？

2.在血液篩檢市場的預測期內，我們應該考慮投資哪些產品和應用？

3.血液篩檢市場的技術趨勢和法規結構是什麼？

4.血液篩檢市場主要廠商的市場佔有率為何？

5. 進入血液篩檢市場適合的形式和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 捐血需求和捐血次數增加
      • 感染疾病的傳播和新病原體的出現
      • 提高血液篩檢核酸檢測的可負擔性和採用率
    • 抑制因素
      • 血液篩檢診斷費用高
    • 機會
      • 血液篩檢設備的技術進步
      • 改善血液篩檢POC 診斷
    • 任務
      • 缺乏血液篩檢的法律、法規和政策
  • 市場區隔分析
    • 產品：更多採用設備和耗材來執行準確的測試
    • 技術：酵素免疫分析法和質譜分析的發展
    • 用途：在檢測感染疾病和癌症、預防感染傳播方面有重要用途
    • 最終用戶：醫院和實驗室更多地使用血液篩檢
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章血液篩檢市場：依產品及服務分類

  • 介紹
  • 裝置
  • 完成購買
  • 試劑和套件

第7章血液篩檢市場：依技術分類

  • 介紹
  • ELISA
  • NAT
  • NGS
  • 快速測試
  • 西方墨點法分析

第8章血液篩檢市場：依最終用戶分類

  • 介紹
  • 血庫
  • 醫院

第9章美洲血液篩檢市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太血液篩檢市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲的血液篩檢市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-374DB5A06BE3

[193 Pages Report] The Blood Screening Market size was estimated at USD 4.90 billion in 2023 and expected to reach USD 5.31 billion in 2024, at a CAGR 8.74% to reach USD 8.82 billion by 2030.

Blood screening is a crucial aspect of healthcare that involves analyzing and testing blood samples to detect potential health issues, infections, or disorders. It serves as a vital diagnostic and monitoring tool, ensuring the safety of blood transfusions organ transplants, and tracking the prevalence of various diseases in a population. The increasing number of blood donations/transfusions worldwide, the rising prevalence of infectious disorders, and technological advancements in molecular diagnostics increase the need for blood screening. However, high upfront costs associated with implementing new technologies and a lack of awareness about available tools in underdeveloped regions significantly impede the adoption of blood screening. Additionally, manufacturers focusing on next-generation sequencing (NGS), CRISPR gene-editing techniques, and artificial intelligence (AI) diagnostics applications offer promising avenues for improving testing accuracy, speed, and cost-efficiency. Manufacturers identify novel biomarkers for various diseases and enhance early detection capabilities, leading to better patient outcomes and increased demand for advanced blood screening tests.

KEY MARKET STATISTICS
Base Year [2023] USD 4.90 billion
Estimated Year [2024] USD 5.31 billion
Forecast Year [2030] USD 8.82 billion
CAGR (%) 8.74%

Product: Rising adoption of instruments and consumables for conducting accurate tests

The blood screening process relies heavily on sophisticated instruments capable of conducting rapid and accurate tests for various pathogens. These instruments help detect infectious agents and enable healthcare professionals to quantify their presence in a given sample. Consumables facilitate accurate and efficient testing while minimizing risks associated with cross-contamination between samples. Consumables in blood screening include micropipette tips, microplates, filter tips & tubes, cuvettes & vials, syringe filters, and other disposable equipment. Blood screening also heavily depends on various reagents that react with specific pathogens or compounds within a sample to produce measurable signals indicating the presence of infectious agents.

Technology: Development of enzyme-linked immunosorbent assay and mass spectrometry technology

Nucleic acid testing (NAT) is a sensitive molecular technique for detecting viral nucleic acids at very low levels in blood samples. Enzyme-linked immunosorbent assay (ELISA) is an immunoassay technique utilized to screen blood samples for antibodies and antigens related to infectious diseases such as HIV, Hepatitis B and C, and Syphilis. Polymerase chain reaction (PCR) is another widely-used molecular diagnostic method that enables rapid detection of specific nucleic acid sequences within a given sample. Mass spectrometry (MS) is an analytical process for identifying and characterizing molecules based on their mass-to-charge ratio (m/z). Flow cytometry is a cell-based technology that allows for rapid analysis of cellular properties by measuring the scattering of light as cells flow through a laser beam.

Application: Significant applications of infectious disease and cancer screening to prevent the spread of infections

Blood screening for infectious diseases is critical for supporting public health and preventing the spread of infections. Blood typing is an essential blood screening process to determine an individual's blood group (ABO system) and Rh factor (positive or negative). Early detection through cancer-specific blood screening has become increasingly relevant with advancements in diagnostic technology. Genetic blood tests analyze DNA to identify inherited disorders, assess the risk of developing specific diseases, and guide personalized treatment plans.

End-User: Increasing use of blood screening in hospitals and laboratories

Hospitals & clinics serve as primary contact points for patients needing blood tests as part of their medical treatment or diagnosis. They collect and process samples on-site or send them to external laboratories for further analysis. Diagnostic laboratories specialize in analyzing biological samples through an array of testing methods such as nucleic acid amplification tests (NAAT), enzyme-linked immunosorbent assay (ELISA), or chemiluminescent immunoassay (CIA). For transfusion, blood banks collect, store, process, test, and distribute blood products, such as whole blood, plasma, platelets, red cells, and white cells. Research institutions, including universities, government agencies, and private organizations, contribute to the development of novel technologies and methodologies for blood screening.

Regional Insights

In the Americas, the demand for blood screening tests is increasing due to their advanced healthcare systems, high-quality research institutions, and funding for innovation. The U.S. Food and Drug Administration (FDA) significantly approves new blood screening technologies to ensure safety and efficacy. In Asia Pacific, rapid economic growth, expanding healthcare infrastructure, and a large patient population are prone to infectious diseases due to high population density. China has recently implemented stringent blood safety regulations following past transfusion-related scandals, leading to increased demand for advanced screening technologies. The European Union (EU) countries have a highly developed healthcare system with strict blood transfusion services regulations. Investments in R&D activities focused on novel diagnostic technologies contribute to Europe's robust blood screening industry. The Middle East & Africa region showcases a diverse landscape with varying levels of healthcare infrastructure development. Many African countries face challenges relating to inadequate infrastructure and resources for ensuring safe transfusions, posing health risks to recipients.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Blood Screening Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Blood Screening Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Blood Screening Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alfa Scientific Designs, Inc., Becton, Dickinson And Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, bioMerieux SA, Danaher Corporation, DiaSorin S.p.A., Environmental & Scientific Instruments Co., F. Hoffmann-La Roche AG, GE HealthCare Technologies, Inc., GFE, Grifols, S.A., Immucor, Inc., Laboratory Corporation of America Holdings, Lifeloc Technologies, Inc, Omega Laboratories, Inc., OraSure Technologies, Inc., Ortho Clinical Diagnostics, Inc., PerkinElmer, Inc., PixCell Medical Technologies Ltd., Premier Biotech, Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., and Trinity Biotech Plc.

Market Segmentation & Coverage

This research report categorizes the Blood Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product & Service
    • Instruments
    • Outright Purchase
    • Reagents & Kits
      • ELISA Reagents & Kits
        • Conjugates
        • Controls
        • Immunosorbents
        • Sample Diluents & Wash Solutions
        • Substrates
      • NAT Reagents & Kits
        • Buffers, Nucleotides, & Solutions
        • Enzymes & Polymerases
        • Labeling & Detection Reagents
        • Probes & Primers
        • Standards & Controls
  • Technology
    • ELISA
      • Chemiluminescent Immunoassay
      • Colorimetric Immunoassay
      • Fluorescent immunoassay
    • NAT
      • Real-Time Polymerase Chain Reaction
      • Transcription-Mediated Amplification
    • NGS
    • Rapid Tests
    • Western Blot Assays
  • End-User
    • Blood Banks
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Blood Screening Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Blood Screening Market?

3. What are the technology trends and regulatory frameworks in the Blood Screening Market?

4. What is the market share of the leading vendors in the Blood Screening Market?

5. Which modes and strategic moves are suitable for entering the Blood Screening Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand for donated blood and rising number of blood donations
      • 5.1.1.2. Rising prevalence of infectious diseases and the emergence of newer pathogens
      • 5.1.1.3. Increase in affordability and adoption of nucleic acid test for blood screening
    • 5.1.2. Restraints
      • 5.1.2.1. High price for blood screening diagnostics
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological Advancements in blood screening devices
      • 5.1.3.2. Improved POC diagnostics for blood screening
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of legislation, regulations, and policies on blood screening
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Rising adoption of instruments and consumables for conducting accurate tests
    • 5.2.2. Technology: Development of enzyme-linked immunosorbent assay and mass spectrometry technology
    • 5.2.3. Application: Significant applications of infectious disease and cancer screening to prevent the spread of infections
    • 5.2.4. End-User: Increasing use of blood screening in hospitals and laboratories
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Blood Screening Market, by Product & Service

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Outright Purchase
  • 6.4. Reagents & Kits

7. Blood Screening Market, by Technology

  • 7.1. Introduction
  • 7.2. ELISA
  • 7.3. NAT
  • 7.4. NGS
  • 7.5. Rapid Tests
  • 7.6. Western Blot Assays

8. Blood Screening Market, by End-User

  • 8.1. Introduction
  • 8.2. Blood Banks
  • 8.3. Hospitals

9. Americas Blood Screening Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Blood Screening Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Blood Screening Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Harbinger Health Raises $140M to Study Blood-Based Cancer Screening Test
    • 12.3.2. Oxford Biodynamics Announces US Launch of its 94% Accurate EpiSwitch Prostate Screening Blood Test to Men With Prostate Cancer Risk
    • 12.3.3. Walgreens and Freenome to Advance Blood-Based Test Trials For Cancer
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. BLOOD SCREENING MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD SCREENING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BLOOD SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD SCREENING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL BLOOD SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BLOOD SCREENING MARKET DYNAMICS
  • FIGURE 7. GLOBAL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BLOOD SCREENING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL BLOOD SCREENING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES BLOOD SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES BLOOD SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. BLOOD SCREENING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. BLOOD SCREENING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BLOOD SCREENING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BLOOD SCREENING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD SCREENING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD SCREENING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD SCREENING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD SCREENING MARKET SIZE, BY OUTRIGHT PURCHASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD SCREENING MARKET SIZE, BY OUTRIGHT PURCHASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD SCREENING MARKET SIZE, BY CONJUGATES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD SCREENING MARKET SIZE, BY CONJUGATES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD SCREENING MARKET SIZE, BY CONTROLS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD SCREENING MARKET SIZE, BY CONTROLS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD SCREENING MARKET SIZE, BY IMMUNOSORBENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD SCREENING MARKET SIZE, BY IMMUNOSORBENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD SCREENING MARKET SIZE, BY SAMPLE DILUENTS & WASH SOLUTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD SCREENING MARKET SIZE, BY SAMPLE DILUENTS & WASH SOLUTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD SCREENING MARKET SIZE, BY SUBSTRATES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD SCREENING MARKET SIZE, BY SUBSTRATES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD SCREENING MARKET SIZE, BY BUFFERS, NUCLEOTIDES, & SOLUTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD SCREENING MARKET SIZE, BY BUFFERS, NUCLEOTIDES, & SOLUTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD SCREENING MARKET SIZE, BY ENZYMES & POLYMERASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD SCREENING MARKET SIZE, BY ENZYMES & POLYMERASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD SCREENING MARKET SIZE, BY LABELING & DETECTION REAGENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD SCREENING MARKET SIZE, BY LABELING & DETECTION REAGENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD SCREENING MARKET SIZE, BY PROBES & PRIMERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD SCREENING MARKET SIZE, BY PROBES & PRIMERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD SCREENING MARKET SIZE, BY STANDARDS & CONTROLS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD SCREENING MARKET SIZE, BY STANDARDS & CONTROLS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD SCREENING MARKET SIZE, BY ELISA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD SCREENING MARKET SIZE, BY ELISA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD SCREENING MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD SCREENING MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD SCREENING MARKET SIZE, BY COLORIMETRIC IMMUNOASSAY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD SCREENING MARKET SIZE, BY COLORIMETRIC IMMUNOASSAY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD SCREENING MARKET SIZE, BY FLUORESCENT IMMUNOASSAY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD SCREENING MARKET SIZE, BY FLUORESCENT IMMUNOASSAY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD SCREENING MARKET SIZE, BY NAT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD SCREENING MARKET SIZE, BY NAT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD SCREENING MARKET SIZE, BY REAL-TIME POLYMERASE CHAIN REACTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD SCREENING MARKET SIZE, BY REAL-TIME POLYMERASE CHAIN REACTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD SCREENING MARKET SIZE, BY TRANSCRIPTION-MEDIATED AMPLIFICATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD SCREENING MARKET SIZE, BY TRANSCRIPTION-MEDIATED AMPLIFICATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD SCREENING MARKET SIZE, BY NGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD SCREENING MARKET SIZE, BY NGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD SCREENING MARKET SIZE, BY RAPID TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD SCREENING MARKET SIZE, BY RAPID TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD SCREENING MARKET SIZE, BY WESTERN BLOT ASSAYS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD SCREENING MARKET SIZE, BY WESTERN BLOT ASSAYS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD SCREENING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD SCREENING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 75. GLOBAL BLOOD SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 76. GLOBAL BLOOD SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 77. AMERICAS BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 78. AMERICAS BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 79. AMERICAS BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 80. AMERICAS BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 81. AMERICAS BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 82. AMERICAS BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 83. AMERICAS BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 84. AMERICAS BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 85. AMERICAS BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 86. AMERICAS BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 87. AMERICAS BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
  • TABLE 88. AMERICAS BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
  • TABLE 89. AMERICAS BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
  • TABLE 90. AMERICAS BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
  • TABLE 91. AMERICAS BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 92. AMERICAS BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 93. AMERICAS BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 94. AMERICAS BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 95. ARGENTINA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 96. ARGENTINA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 97. ARGENTINA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 98. ARGENTINA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 99. ARGENTINA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 100. ARGENTINA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 101. ARGENTINA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 102. ARGENTINA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 103. ARGENTINA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 104. ARGENTINA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 105. ARGENTINA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
  • TABLE 106. ARGENTINA BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
  • TABLE 107. ARGENTINA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
  • TABLE 108. ARGENTINA BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
  • TABLE 109. ARGENTINA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 110. ARGENTINA BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 111. BRAZIL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 112. BRAZIL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 113. BRAZIL BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 114. BRAZIL BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 115. BRAZIL BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 116. BRAZIL BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 117. BRAZIL BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 118. BRAZIL BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 119. BRAZIL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 120. BRAZIL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 121. BRAZIL BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
  • TABLE 122. BRAZIL BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
  • TABLE 123. BRAZIL BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
  • TABLE 124. BRAZIL BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
  • TABLE 125. BRAZIL BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 126. BRAZIL BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 127. CANADA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 128. CANADA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 129. CANADA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 130. CANADA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 131. CANADA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 132. CANADA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 133. CANADA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 134. CANADA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 135. CANADA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 136. CANADA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 137. CANADA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
  • TABLE 138. CANADA BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
  • TABLE 139. CANADA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
  • TABLE 140. CANADA BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
  • TABLE 141. CANADA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 142. CANADA BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 143. MEXICO BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 144. MEXICO BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 145. MEXICO BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 146. MEXICO BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 147. MEXICO BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 148. MEXICO BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 149. MEXICO BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 150. MEXICO BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 151. MEXICO BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 152. MEXICO BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 153. MEXICO BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
  • TABLE 154. MEXICO BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
  • TABLE 155. MEXICO BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
  • TABLE 156. MEXICO BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
  • TABLE 157. MEXICO BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 158. MEXICO BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 159. UNITED STATES BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 160. UNITED STATES BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 161. UNITED STATES BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 162. UNITED STATES BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 163. UNITED STATES BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 164. UNITED STATES BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 165. UNITED STATES BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 166. UNITED STATES BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 167. UNITED STATES BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 168. UNITED STATES BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 169. UNITED STATES BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
  • TABLE 170. UNITED STATES BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
  • TABLE 171. UNITED STATES BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
  • TABLE 172. UNITED STATES BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
  • TABLE 173. UNITED STATES BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 174. UNITED STATES BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 175. UNITED STATES BLOOD SCREENING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 176. UNITED STATES BLOOD SCREENING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 195. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 196. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 197. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 198. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 199. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 200. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 201. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 202. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 203. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 204. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 205. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
  • TABLE 206. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
  • TABLE 207. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
  • TABLE 208. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
  • TABLE 209. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. CHINA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 212. CHINA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 213. CHINA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 214. CHINA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 215. CHINA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 216. CHINA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 217. CHINA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 218. CHINA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 219. CHINA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 220. CHINA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 221. CHINA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
  • TABLE 222. CHINA BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
  • TABLE 223. CHINA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
  • TABLE 224. CHINA BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
  • TABLE 225. CHINA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 226. CHINA BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 227. INDIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 228. INDIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 229. INDIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 230. INDIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 231. INDIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 232. INDIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 233. INDIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 234. INDIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 235. INDIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 236. INDIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 237. INDIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
  • TABLE 238. INDIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
  • TABLE 239. INDIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
  • TABLE 240. INDIA BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
  • TABLE 241. INDIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 242. INDIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 243. INDONESIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 244. INDONESIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 245. INDONESIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 246. INDONESIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 247. INDONESIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 248. INDONESIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 249. INDONESIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 250. INDONESIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 251. INDONESIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 252. INDONESIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 253. INDONESIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
  • TABLE 254. INDONESIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
  • TABLE 255. INDONESIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
  • TABLE 256. INDONESIA BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
  • TABLE 257. INDONESIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 258. INDONESIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 259. JAPAN BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 260. JAPAN BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 261. JAPAN BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 262. JAPAN BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 263. JAPAN BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 264. JAPAN BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 265. JAPAN BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 266. JAPAN BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 267. JAPAN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 268. JAPAN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 269. JAPAN BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
  • TABLE 270. JAPAN BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
  • TABLE 271. JAPAN BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
  • TABLE 272. JAPAN BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
  • TABLE 273. JAPAN BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 274. JAPAN BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 275. MALAYSIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 276. MALAYSIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 277. MALAYSIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 278. MALAYSIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 279. MALAYSIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 280. MALAYSIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 281. MALAYSIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 282. MALAYSIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 283. MALAYSIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 284. MALAYSIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 285. MALAYSIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
  • TABLE 286. MALAYSIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
  • TABLE 287. MALAYSIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
  • TABLE 288. MALAYSIA BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
  • TABLE 289. MALAYSIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 290. MALAYSIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 291. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 292. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 293. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 294. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 295. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 296. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 297. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 298. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 299. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 300. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 301. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
  • TABLE 302. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
  • TABLE 303. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
  • TABLE 304. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
  • TABLE 305. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 306. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 307. SINGAPORE BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 308. SINGAPORE BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 309. SINGAPORE BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 310. SINGAPORE BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 311. SINGAPORE BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 312. SINGAPORE BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 313. SINGAPORE BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 314. SINGAPORE BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 315. SINGAPORE BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 316. SINGAPORE BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 317. SINGAPORE BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
  • TABLE 318. SINGAPORE BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
  • TABLE 319. SINGAPORE BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
  • TABLE 320. SINGAPORE BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
  • TABLE 321. SINGAPORE BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 322. SINGAPORE BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 323. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 324. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 325. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 326. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 327. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 328. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 329. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 330. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 331. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 332. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 333. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
  • TABLE 334. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
  • TABLE 335. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
  • TABLE 336. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
  • TABLE 337. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 338. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 339. TAIWAN BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 340. TAIWAN BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 341. TAIWAN BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 342. TAIWAN BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 343. TAIWAN BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 344. TAIWAN BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 345. TAIWAN BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 346. TAIWAN BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 347. TAIWAN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 348. TAIWAN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 349. TAIWAN BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2023 (USD MILLION)
  • TABLE 350. TAIWAN BLOOD SCREENING MARKET SIZE, BY ELISA, 2024-2030 (USD MILLION)
  • TABLE 351. TAIWAN BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2023 (USD MILLION)
  • TABLE 352. TAIWAN BLOOD SCREENING MARKET SIZE, BY NAT, 2024-2030 (USD MILLION)
  • TABLE 353. TAIWAN BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 354. TAIWAN BLOOD SCREENING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 355. THAILAND BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 356. THAILAND BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 357. THAILAND BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (US